CHRONIC CONVECTION ENHANCED DELIVERY OF TOPOTECAN FOR RECURRENT HIGH GRADE GLIOMA

Protocol: 
AAAQ9520
Phase: 
I

CHRONIC CONVECTION ENHANCED DELIVERY OF TOPOTECAN FOR RECURRENT HIGH GRADE GLIOMA

Are you Eligible? (Inclusion Criteria)

1. Patients must have a recurrent malignant glioma
2. Patients need to have a performance status where they may require
occasional assistance, but is able to care for most of their personal needs.
3. Patients must be willing to and medically capable of undergoing the
surgical operation.

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States